back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2022-06-21 11:40 Tx date 2022-06-20 |
$VIV
Avivagen Inc. |
Mesburis, Paul
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+80,000 vol |
423,446 | |
| Filed 2021-03-10 11:16 Tx date 2021-03-08 |
$VIV
Avivagen Inc. |
Mesburis, Paul
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+60,000 vol |
343,446 | |
| Filed 2020-03-10 09:58 Tx date 2020-03-06 |
$VIV
Avivagen Inc. |
Mesburis, Paul
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+60,000 vol |
283,446 | |
| Filed 2019-12-20 13:27 Tx date 2019-12-19 |
$
Logica Ventures Corp. |
Mesburis, Paul
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+175,000 vol |
175,000 | |
| Filed 2019-12-20 13:27 Tx date 2019-10-16 |
$
Logica Ventures Corp. |
Mesburis, Paul
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-10-22 15:10 Tx date 2019-10-16 |
$
Logica Ventures Corp. |
Mesburis, Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares 1,340,000
00 - Opening Balance-Initial SEDI Report
|
560,000 | ||
| Filed 2019-06-10 16:39 Tx date 2019-05-27 |
$PLI
Prometic Life Sciences Inc. |
Mesburis, Paul
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-147,024.90
-133,659 vol $1.10 each |
394,094 | |
| Filed 2019-06-09 12:12 Tx date 2019-06-06 |
$VIV
Avivagen Inc. |
Mesburis, Paul
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+60,000 vol |
223,446 | |
| Filed 2019-05-31 15:20 Tx date 2019-05-28 |
$PLI
Prometic Life Sciences Inc. |
Mesburis, Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-13,400
-335,000 vol $0.04 each |
0 | |
| Filed 2019-05-31 15:19 Tx date 2019-05-28 |
$PLI
Prometic Life Sciences Inc. |
Mesburis, Paul
4 - Director of Issuer
Holder: RESP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-9,040
-226,000 vol $0.04 each |
0 | |
| Filed 2019-05-24 15:41 Tx date 2019-05-23 |
$PLI
Prometic Life Sciences Inc. |
Mesburis, Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,000
+200,000 vol $0.05 each |
335,000 | |
| Filed 2019-05-24 15:41 Tx date 2019-05-22 |
$PLI
Prometic Life Sciences Inc. |
Mesburis, Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,750
+135,000 vol $0.05 each |
135,000 | |
| Filed 2019-05-24 15:39 Tx date 2019-05-22 |
$PLI
Prometic Life Sciences Inc. |
Mesburis, Paul
4 - Director of Issuer
Holder: In trust - Child (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-840.00
-21,000 vol $0.04 each |
0 | |
| Filed 2019-05-24 15:39 Tx date 2019-05-22 |
$PLI
Prometic Life Sciences Inc. |
Mesburis, Paul
4 - Director of Issuer
Holder: TFSA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,633.31
-58,518 vol $0.045 each |
0 | |
| Filed 2019-05-24 15:38 Tx date 2019-05-22 |
$PLI
Prometic Life Sciences Inc. |
Mesburis, Paul
4 - Director of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-920.00
-23,000 vol $0.04 each |
0 | |
| Filed 2019-05-24 15:38 Tx date 2019-05-22 |
$PLI
Prometic Life Sciences Inc. |
Mesburis, Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-11,990.84
-299,771 vol $0.04 each |
0 | |
| Filed 2018-12-31 Tx date 2018-12-31 |
$PLI
Prometic Life Sciences Inc. |
Mesburis, Paul
4 - Director of Issuer
Holder: TFSA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,994
+22,200 vol $0.27 each |
58,518 | |
| Filed 2018-12-17 Tx date 2018-12-14 |
$PLI
Prometic Life Sciences Inc. |
Mesburis, Paul
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-17,000
-50,000 vol $0.34 each |
527,753 | |
| Filed 2018-12-07 Tx date 2018-12-04 |
$PLI
Prometic Life Sciences Inc. |
Mesburis, Paul
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$139,999
+181,818 vol $0.77 each |
577,753 | |
| Filed 2018-05-08 Tx date 2018-05-07 |
$PLI
Prometic Life Sciences Inc. |
Mesburis, Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
-1,325 vol |
299,771 | |
| Filed 2018-05-08 Tx date 2018-05-07 |
$PLI
Prometic Life Sciences Inc. |
Mesburis, Paul
4 - Director of Issuer
Holder: TFSA (Indirect Ownership)
|
Common Shares
90 - Change in the nature of ownership
|
+1,325 vol |
36,318 | |
| Filed 2018-05-03 Tx date 2018-04-16 |
$ESU
EEStor Corporation |
Mesburis, Paul
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
1,440,000 | |
| Filed 2018-04-16 Tx date 2018-04-12 |
$VIV
Avivagen Inc. |
Mesburis, Paul
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+58,135 vol |
163,446 | |
| Filed 2017-09-28 Tx date 2017-04-06 |
$ESU
EEStor Corporation |
Mesburis, Paul
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
$142,500
+250,000 vol $0.57 each |
1,240,000 | |
| Filed 2017-08-28 Tx date 2017-08-24 |
$PLI
ProMetic Life Sciences Inc. |
Mesburis, Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$6,000
+50,000 vol $0.12 each |
322,514 | |
| Filed 2017-08-28 Tx date 2017-08-24 |
$PLI
ProMetic Life Sciences Inc. |
Mesburis, Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-25,059.06
-21,418 vol $1.17 each |
301,096 | |
| Filed 2017-08-28 Tx date 2017-08-24 |
$PLI
ProMetic Life Sciences Inc. |
Mesburis, Paul
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-6,000
-50,000 vol $0.12 each |
395,935 | |
| Filed 2017-06-02 Tx date 2017-05-30 |
$VIV
Avivagen Inc. |
Mesburis, Paul
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+45,311 vol |
105,311 | |
| Filed 2017-05-23 Tx date 2017-05-18 |
$PLI
ProMetic Life Sciences Inc. |
Mesburis, Paul
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$143,579
+69,362 vol $2.07 each |
445,935 | |
| Filed 2017-05-16 Tx date 2017-05-12 |
$VIV
Avivagen Inc. |
Mesburis, Paul
4 - Director of Issuer
Direct Ownership
|
Warrants
37 - Stock split or consolidation
|
-78,750 vol |
8,750 | |
| Filed 2017-05-16 Tx date 2017-05-12 |
$VIV
Avivagen Inc. |
Mesburis, Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-157,500 vol |
17,500 | |
| Filed 2017-05-16 Tx date 2017-05-12 |
$VIV
Avivagen Inc. |
Mesburis, Paul
4 - Director of Issuer
Holder: Spousal RRSP (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-40,860 vol |
4,540 | |
| Filed 2017-05-16 Tx date 2017-05-12 |
$VIV
Avivagen Inc. |
Mesburis, Paul
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-540,000 vol |
60,000 | |
| Filed 2017-03-16 Tx date 2016-12-20 |
$ESU
EEStor Corporation |
Mesburis, Paul
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
+450,000 vol |
990,000 | |
| Filed 2016-11-01 Tx date 2016-10-31 |
$VIV
Avivagen Inc. |
Mesburis, Paul
4 - Director of Issuer
Holder: Spousal RRSP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,944
+45,400 vol $0.175 each |
45,400 | |
| Filed 2016-11-01 Tx date 2016-04-05 |
$VIV
Avivagen Inc. |
Mesburis, Paul
4 - Director of Issuer
Holder: Spousal RRSP (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-08-10 Tx date 2016-08-05 |
$ESU
EEStor Corporation |
Mesburis, Paul
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
$48,600
+180,000 vol $0.27 each |
540,000 | |
| Filed 2016-06-23 Tx date 2016-04-05 |
$VIV
Avivagen Inc. |
Mesburis, Paul
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-06-23 Tx date 2016-06-22 |
$VIV
Avivagen Inc. |
Mesburis, Paul
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+600,000 vol |
600,000 | |
| Filed 2016-06-06 Tx date 2016-06-01 |
$VIV
Avivagen Inc. |
Mesburis, Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$10,500
+175,000 vol $0.06 each |
175,000 | |
| Filed 2016-06-06 Tx date 2016-06-01 |
$VIV
Avivagen Inc. |
Mesburis, Paul
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+87,500 vol |
87,500 | |
| Filed 2016-06-06 Tx date 2016-04-05 |
$VIV
Avivagen Inc. |
Mesburis, Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-06-06 Tx date 2016-04-05 |
$VIV
Avivagen Inc. |
Mesburis, Paul
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-06-03 Tx date 2016-06-02 |
$PLI
ProMetic Life Sciences Inc. |
Mesburis, Paul
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-7,500
-50,000 vol $0.15 each |
376,573 | |
| Filed 2016-06-03 Tx date 2016-06-02 |
$PLI
ProMetic Life Sciences Inc. |
Mesburis, Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$7,500
+50,000 vol $0.15 each |
272,514 | |
| Filed 2016-05-30 Tx date 2016-05-25 |
$PLI
ProMetic Life Sciences Inc. |
Mesburis, Paul
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$186,612
+62,204 vol $3.00 each |
426,573 | |
| Filed 2016-02-24 Tx date 2016-02-22 |
$ESU
EEStor Corporation |
Mesburis, Paul
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
16 - Acquisition or disposition under a prospectus exemption
|
$4,950
+33,000 vol $0.15 each |
||
| Filed 2016-02-24 Tx date 2016-02-23 |
$ESU
EEStor Corporation |
Mesburis, Paul
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
$35,100
+180,000 vol $0.195 each |
360,000 | |
| Filed 2016-02-24 Tx date 2014-06-02 |
$ESU
EEStor Corporation |
Mesburis, Paul
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-02-24 Tx date 2016-02-22 |
$ESU
EEStor Corporation |
Mesburis, Paul
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$9,900
+33,000 vol $0.30 each |
33,000 | |
| Filed 2016-02-24 Tx date 2016-02-22 |
$ESU
EEStor Corporation |
Mesburis, Paul
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$4,950
+33,000 vol $0.15 each |
207,100 | |
| Filed 2016-02-24 Tx date 2016-02-22 |
$ESU
EEStor Corporation |
Mesburis, Paul
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
16 - Acquisition or disposition under a prospectus exemption
|
$4,950
+33,000 vol $0.15 each |
||
| Filed 2016-01-05 Tx date 2016-01-05 |
$PLI
ProMetic Life Sciences Inc. |
Mesburis, Paul
4 - Director of Issuer
Holder: TFSA (Indirect Ownership)
|
Common Shares
90 - Change in the nature of ownership
|
+1,687 vol |
34,993 | |
| Filed 2016-01-05 Tx date 2016-01-05 |
$PLI
ProMetic Life Sciences Inc. |
Mesburis, Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
-1,687 vol |
222,514 | |
| Filed 2015-11-17 Tx date 2015-11-17 |
$PLI
ProMetic Life Sciences Inc. |
Mesburis, Paul
4 - Director of Issuer
Holder: TFSA (Indirect Ownership)
|
Common Shares
90 - Change in the nature of ownership
|
+10,706 vol |
33,306 | |
| Filed 2015-11-17 Tx date 2015-11-17 |
$PLI
ProMetic Life Sciences Inc. |
Mesburis, Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
-10,706 vol |
224,201 | |
| Filed 2015-06-22 Tx date 2015-06-22 |
$PLI
ProMetic Life Sciences Inc. |
Mesburis, Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-50,175
-22,500 vol $2.23 each |
234,907 | |
| Filed 2015-06-12 Tx date 2015-06-08 |
$PLI
ProMetic Life Sciences Inc. |
Mesburis, Paul
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+80,710 vol |
364,369 | |
| Filed 2015-06-05 Tx date 2015-06-04 |
$PLI
ProMetic Life Sciences Inc. |
Mesburis, Paul
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-36,000
-200,000 vol $0.18 each |
283,659 | |
| Filed 2015-06-05 Tx date 2015-06-04 |
$PLI
ProMetic Life Sciences Inc. |
Mesburis, Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$36,000
+200,000 vol $0.18 each |
373,000 | |
| Filed 2015-06-05 Tx date 2015-06-04 |
$PLI
ProMetic Life Sciences Inc. |
Mesburis, Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-277,423.20
-115,593 vol $2.40 each |
257,407 |